Fulton Bank N.A. Lowers Stock Position in CVS Health Corporation $CVS

Fulton Bank N.A. trimmed its holdings in shares of CVS Health Corporation (NYSE:CVS) by 29.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,836 shares of the pharmacy operator’s stock after selling 10,539 shares during the quarter. Fulton Bank N.A.’s holdings in CVS Health were worth $1,872,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in shares of CVS Health by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after acquiring an additional 2,063,737 shares during the period. State Street Corp boosted its position in CVS Health by 1.4% during the second quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock valued at $4,055,237,000 after purchasing an additional 800,414 shares in the last quarter. Geode Capital Management LLC grew its stake in CVS Health by 2.4% in the second quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock valued at $1,966,083,000 after purchasing an additional 675,824 shares during the last quarter. Invesco Ltd. raised its holdings in CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after purchasing an additional 3,118,626 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of CVS Health during the second quarter valued at about $1,358,698,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. Truist Financial set a $100.00 price objective on shares of CVS Health in a research report on Wednesday, December 10th. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Morgan Stanley increased their price objective on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Leerink Partners boosted their target price on CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Finally, Barclays upped their target price on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $94.67.

CVS Health Stock Performance

Shares of CVS stock opened at $80.04 on Friday. The business has a fifty day moving average of $78.67 and a 200 day moving average of $73.41. CVS Health Corporation has a 1 year low of $44.14 and a 1 year high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The firm has a market capitalization of $101.61 billion, a price-to-earnings ratio of 210.64, a price-to-earnings-growth ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period in the prior year, the company earned $1.09 earnings per share. The company’s revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.